Pulmonx (LUNG) Shares Outstanding (Diluted Average) (2020 - 2025)

Pulmonx (LUNG) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $40.9 million in Q3 2025.

• Shares Outstanding (Diluted Average) for Q3 2025 came in at $40.9 million, up 5.09% year-over-year; the trailing twelve-month figure through Sep 2025 was $40.9 million (up 5.09% YoY), and the FY2024 annual result was $39.1 million, up 2.99% from the prior year.
• Shares Outstanding (Diluted Average) grew to $40.9 million in Q3 2025 per LUNG's latest filing, from $40.4 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $40.9 million in Q3 2025 and troughed at $35.4 million in Q1 2021.
• A 5-year average of $37.9 million and a median of $37.8 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Diluted Average) surged 1744.99% in 2021, then gained 1.51% in 2022.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $36.1 million in 2021, then gained by 2.68% to $37.1 million in 2022, then rose by 2.37% to $38.0 million in 2023, then gained by 2.99% to $39.1 million in 2024, then increased by 4.67% to $40.9 million in 2025.
• Business Quant data shows LUNG's Shares Outstanding (Diluted Average) at $40.9 million in Q3 2025, $40.4 million in Q2 2025, and $40.0 million in Q1 2025.